Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure.
Caprnda M, Zulli A, Shiwani HA, Kubatka P, Filipova S, Valentova V, Gazdikova K, Mozos I, Berukstis A, Laucevicius A, Rihacek I, Dragasek J, Prosecky R, Egom EE, Staffa R, Kruzliak P, Krasnik V. Caprnda M, et al. Among authors: shiwani ha. Clin Exp Pharmacol Physiol. 2020 Jul;47(7):1120-1133. doi: 10.1111/1440-1681.13290. Epub 2020 Mar 20. Clin Exp Pharmacol Physiol. 2020. PMID: 32083749 Review.
A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Pasumarthi KBS, Ribama HA. Egom EE, et al. Among authors: shiwani ha. Biomed Pharmacother. 2017 Sep;93:1144-1150. doi: 10.1016/j.biopha.2017.07.027. Epub 2017 Jul 19. Biomed Pharmacother. 2017. PMID: 28738523
New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Rose RA, Pasumarthi KB, Ribama HA. Egom EE, et al. Among authors: shiwani ha. Int J Physiol Pathophysiol Pharmacol. 2017 Sep 1;9(4):112-118. eCollection 2017. Int J Physiol Pathophysiol Pharmacol. 2017. PMID: 28951773 Free PMC article.
Erratum: New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease.
Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, El Hiani Y, Rose RA, Pasumarthi KB, Ribama HA. Egom EE, et al. Among authors: shiwani ha. Int J Physiol Pathophysiol Pharmacol. 2017 Nov 1;9(5):164. eCollection 2017. Int J Physiol Pathophysiol Pharmacol. 2017. PMID: 29218116 Free PMC article.
An update on the 2014 Ebola outbreak in Western Africa.
Shiwani HA, Pharithi RB, Khan B, Egom CB, Kruzliak P, Maher V, Egom EE. Shiwani HA, et al. Asian Pac J Trop Med. 2017 Jan;10(1):6-10. doi: 10.1016/j.apjtm.2016.12.008. Epub 2016 Dec 27. Asian Pac J Trop Med. 2017. PMID: 28107867 Free article. Review.
Updates on sphingolipids: Spotlight on retinopathy.
Shiwani HA, Elfaki MY, Memon D, Ali S, Aziz A, Egom EE. Shiwani HA, et al. Biomed Pharmacother. 2021 Nov;143:112197. doi: 10.1016/j.biopha.2021.112197. Epub 2021 Sep 21. Biomed Pharmacother. 2021. PMID: 34560541 Free article. Review.
26 results